Diabetes MellitusNCT03683784
Type 2 Diabetes in Fayoum
An observational study of Diabetes Mellitus, run by Fayoum University.
Trial summary
study the prevalence of type II diabetes mellitus, prevalence of newly diagnosed type II diabetic patients Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Diabetes Mellitus
- How many people
- 3,500 participants
- Where
- No sites listed yet
- Study dates
- 1 Jan 2017to 1 Nov 2017
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: obese persons,dyslipidemics ,apparently healthy individuals
Who may be able to join
- community sample as obese persons,family history of diabetes,diabetics,hypertensives,dyslipidemics
Who cannot join
- subjects known to have:chronic liver disease,CKD,Cushing
About this study
Official title: Prevalence of Type 2 Diabetes in Fayoum Governorate
study the prevalence of type II diabetes mellitus, prevalence of newly diagnosed type II diabetic patients
Read the detailed description
study the prevalence of type II diabetes mellitus, prevalence of newly diagnosed type II diabetic patients, status of glycemic control and associated risk factors and complications of diabetes among population of Fayoum governorate
- Conditions
- Diabetes Mellitus
- Medical subject headings
- Diabetes Mellitus
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Males | Male diabetics or male subjects proved to be diabetics | |
| Female | Female diabetics or male subjects proved to be diabetics |
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence of diabetes in Fayoum
Prevalence of diabetes in Fayoum governorate
Measured: 11 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Sep 2018
- Study start1 Jan 2017
- Primary completion1 Nov 2017
- Study completion1 Nov 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Diabetes MellitusStudies of the same condition, open and under way.
- More trials run by Fayoum UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 3,500 participants (actual)
Sponsor and investigators
- Lead sponsor
- Fayoum University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ahmed Abdelkawi Hammad, Fayoum University
- Investigators
- Ahmed A Hammad, MD, Study director, Fayoum University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03683784
- Sponsor's protocol ID
- D75
- Status last verified
- Sep 2018
- First submitted
- 24 Sep 2018
- Last updated
- 25 Sep 2018
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: Probably will
Study at a glance
From the registry record, last updated by the sponsor on 25 Sep 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevalence of Type 2 Diabetes in Fayoum Governorate
- ClinicalTrials.gov ID
- NCT03683784
- Acronym / sponsor ID
- D75
- Conditions
- Diabetes Mellitus
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 3,500 participants (actual)
- Lead sponsor
- Fayoum UniversityUniversity, hospital or other
- Study start
- 1 Jan 2017 (actual)
- Primary completion
- 1 Nov 2017 (actual)
- Study completion
- 1 Nov 2017 (actual)
- First posted
- 25 Sep 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
study the prevalence of type II diabetes mellitus, prevalence of newly diagnosed type II diabetic patients
Detailed description
study the prevalence of type II diabetes mellitus, prevalence of newly diagnosed type II diabetic patients, status of glycemic control and associated risk factors and complications of diabetes among population of Fayoum governorate
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Males | – | –Male diabetics or male subjects proved to be diabetics |
| Female | – | –Female diabetics or male subjects proved to be diabetics |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- obese persons,dyslipidemics ,apparently healthy individuals
Key inclusion criteria (1 listed)
- community sample as obese persons,family history of diabetes,diabetics,hypertensives,dyslipidemics
Key exclusion criteria (1 listed)
- subjects known to have:chronic liver disease,CKD,Cushing
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Prevalence of diabetes in Fayoum
Time frame: 11 months
Prevalence of diabetes in Fayoum governorate
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Sep 2018.
- Individual participant dataSharing planned: Undecided. Probably will
Related trials for Diabetes Mellitus
Active, not recruitingPhase 3
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Not yet recruiting
SWitching to Appropriate Prescription in Cardiovascular-Kidney-Metabolic Syndrome
Cardiovascular-kidney-metabolic Syndrome, Diabete Type 2
Active, not recruiting
Pilot of Continuous Glucose Monitor-Augmented Food Is Medicine
Nutrition, Type 2 Diabetes
RecruitingObservational study
Safety and Effect of Peripheral Nerve Decompression Combined With Peripheral Nerve Stimulation for Painful Diabetic Peripheral Neuropathy
Painful Diabetic Peripheral Neuropathy, Diabetes Complication
Recruiting
Continuous Monitoring of Plantar Temperature Variations Using Connected Insoles and a Mobile Application for Diabetic Foot.
Diabetic Foot Disease, Diabetic Foot Infection
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ahmed A Hammad, MD study director
Fayoum University
Questions about this trial
What is this clinical trial studying?
An observational study of Diabetes Mellitus, run by Fayoum University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Sep 2018. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence of diabetes in Fayoum (time frame: 11 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2018.